Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Haverkate

Showing results (61-70 of 73) with videos related to

Pageof 8
Sort By:
Thrombosis and Haemostasis|August 26, 2000
Fibrinogen Caracas V, an abnormal fibrinogen with an Aalpha 532 Ser-->Cys substitution associated with thrombosisR Marchi, U Lundberg, J Grimbergen, et al.
European Heart Journal|May 25, 1999
Inflammatory status as a main determinant of outcome in patients with unstable angina, independent of coagulation activation and endothelial cell functionP W Verheggen, M P de Maat, V M Cats, et al.
Haemostasis|July 27, 1999
Coagulation and fibrinolysis markers and risk of dementia. The Dutch Vascular Factors in Dementia StudyM L Bots, M M Breteler, F van Kooten, et al.
Surgery|October 1, 1975
Orthotopic liver transplantation: an experimental study on mechanisms of hemorrhagic diathesis and thrombosisS W Schalm, J L Terpstra, J R Achterberg, et al.
Journal of Neurology|February 11, 1998
The Dutch Vascular Factors in Dementia Study: rationale and designF van Kooten, M L Bots, M M Breteler, et al.
The Journal of Clinical Investigation|April 1, 1993
Molecular basis for fibrinogen Dusart (A alpha 554 Arg-->Cys) and its association with abnormal fibrin polymerization and thrombophiliaJ Koopman, F Haverkate, J Grimbergen, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|April 29, 1998
Elevated plasma fibrinogen: cause or consequence of cardiovascular disease?J G van der Bom, M P de Maat, M L Bots, et al.
Haemostasis|July 27, 1999
Response to activated protein C in subjects with and without dementia. The Dutch Vascular Factors in Dementia StudyM L Bots, F van Kooten, M M Breteler, et al.
Annals of Internal Medicine|August 15, 1996
Reduced response to activated protein C is associated with increased risk for cerebrovascular diseaseJ G van der Bom, M L Bots, F Haverkate, et al.
Circulation|June 17, 1997
Tissue plasminogen activator and risk of myocardial infarction. The Rotterdam StudyJ G van der Bom, P de Knijff, F Haverkate, et al.
Pageof 8

Showing results (61-70 of 73) with videos related to

Sort By:
Pageof 8
Thrombosis and Haemostasis|August 26, 2000
Fibrinogen Caracas V, an abnormal fibrinogen with an Aalpha 532 Ser-->Cys substitution associated with thrombosisR Marchi, U Lundberg, J Grimbergen, et al.
European Heart Journal|May 25, 1999
Inflammatory status as a main determinant of outcome in patients with unstable angina, independent of coagulation activation and endothelial cell functionP W Verheggen, M P de Maat, V M Cats, et al.
Haemostasis|July 27, 1999
Coagulation and fibrinolysis markers and risk of dementia. The Dutch Vascular Factors in Dementia StudyM L Bots, M M Breteler, F van Kooten, et al.
Surgery|October 1, 1975
Orthotopic liver transplantation: an experimental study on mechanisms of hemorrhagic diathesis and thrombosisS W Schalm, J L Terpstra, J R Achterberg, et al.
Journal of Neurology|February 11, 1998
The Dutch Vascular Factors in Dementia Study: rationale and designF van Kooten, M L Bots, M M Breteler, et al.
The Journal of Clinical Investigation|April 1, 1993
Molecular basis for fibrinogen Dusart (A alpha 554 Arg-->Cys) and its association with abnormal fibrin polymerization and thrombophiliaJ Koopman, F Haverkate, J Grimbergen, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|April 29, 1998
Elevated plasma fibrinogen: cause or consequence of cardiovascular disease?J G van der Bom, M P de Maat, M L Bots, et al.
Haemostasis|July 27, 1999
Response to activated protein C in subjects with and without dementia. The Dutch Vascular Factors in Dementia StudyM L Bots, F van Kooten, M M Breteler, et al.
Annals of Internal Medicine|August 15, 1996
Reduced response to activated protein C is associated with increased risk for cerebrovascular diseaseJ G van der Bom, M L Bots, F Haverkate, et al.
Circulation|June 17, 1997
Tissue plasminogen activator and risk of myocardial infarction. The Rotterdam StudyJ G van der Bom, P de Knijff, F Haverkate, et al.
Pageof 8